Table 6.
Parameters | control negative (G1) |
CGB (G2) |
AFB1 (G3) |
AFG1 (G4) |
CGB + AFB1 (G5) |
CGB + AFG1 (G6) |
---|---|---|---|---|---|---|
Urea (mg/dL) | 6.91 ± 0.04b | 7.13 ± 0.06b | 9.41 ± 0.28a | 8.94 ± 0.34a | 7.23 ± 0.09b | 7.31 ± 0.06b |
Uric acid (mg/dL) | 2.31 ± 0.02b | 2.26 ± 0.02b | 5.63 ± 0.17a | 5.34 ± 0.11a | 2.71 ± 0.08b | 2.43 ± 0.05b |
Creatinine (mg/dL) | 0.96 ± 0.01b | 0.99 ± 0.04b | 1.32 ± 0.31a | 1.21 ± 0.19a | 1.07 ± 0.05b | 1.03 ± 0.06b |
● Data expressed as means ± SD –; (n = 3, P>0.05) –; CGB: Cape-goldenberry.
● Oral administration of aflatoxin B1 or Aflatoxin G1 adjusted at 850 ng/kg body weight/day.
● The data in the same raw shared the superscriptions had no significant differences.